Rare lephants
Screener

Protalix BioTherapeutics, Inc.

PLX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
SC 13G Mar 30, 2020 SC 13G
SC 13G Mar 25, 2020 SC 13G
SC 13G Mar 23, 2020 PROTALIX BIOTHERAPEUTICS, INC.
8-K Mar 18, 2020 FORM 8-K
10-K Mar 12, 2020 FORM 10-K
8-K Mar 12, 2020 8-K
8-K Mar 12, 2020 FORM 8-K
SC 13G/A Mar 9, 2020 AMENDED SCHEDULE 13G
SC 13G/A Feb 13, 2020 AMENDMENT NO. 3 TO SCHEDULE 13G
SC 13G/A Feb 13, 2020 AMENDMENT NO. 4 TO SCHEDULE 13G
8-K Feb 10, 2020 FORM 8-K
SC 13G/A Feb 7, 2020 SC 13G/A
8-K Feb 6, 2020 FORM 8-K
4 Feb 5, 2020 OWNERSHIP DOCUMENT
4 Jan 22, 2020 OWNERSHIP DOCUMENT
4 Jan 22, 2020 OWNERSHIP DOCUMENT
4 Jan 22, 2020 OWNERSHIP DOCUMENT
4 Jan 22, 2020 OWNERSHIP DOCUMENT
4 Jan 22, 2020 OWNERSHIP DOCUMENT
3 Jan 3, 2020 OWNERSHIP DOCUMENT
3 Jan 3, 2020 OWNERSHIP DOCUMENT
8-K Dec 20, 2019 FORM 8-K
8-K Dec 19, 2019 FORM 8-K
CT ORDER Dec 17, 2019
8-K Dec 9, 2019 FORM 8-K
← Newer Page 11 of 38 · 935 filings Older →